• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wnt/β-连环蛋白通路在动脉中层钙化中的作用及其对 OPG/RANKL 系统的影响。

Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.

机构信息

Department of Geriatrics, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.

Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

Curr Med Sci. 2019 Feb;39(1):28-36. doi: 10.1007/s11596-019-1996-4. Epub 2019 Mar 13.

DOI:10.1007/s11596-019-1996-4
PMID:30868488
Abstract

In this study, the hypothesis that Wnt/β-catenin pathway is involved in the arterial calcification by regulating the osteoprotegerin (OPG)/receptor activator of NF-κB ligand (RANKL) system was tested. The β-catenin expression was measured in the warfarin-induced calcified arteries and the osteoblast-like cells differentiating from smooth muscle cells (SMCs) by immunohistochemistry and Western blotting. The Wnt/β-catenin pathway was activated or inhibited by lithium chloride (LiCl) or dickkopf 1 (DKK1) in vitro and in vivo. Then the calcification level was determined by von Kossa staining, Ca content assay, and alkaline phosphatase (ALP) activity assay. The expression levels of osteocalcin, OPG and RANKL were detected by Western blotting or real-time PCR. The results showed that in calcified arteries and OBL cells, the activation of Wnt/β-catenin pathway significantly enhanced the calcification as evidenced by increased von Kossa stains, Ca contents, ALP activities, and osteocalcin expression levels (P<0.05), and it promoted the RANKL expression (P<0.05), but slightly affected the OPG expression. These results indicated that the activation of Wnt/β-catenin pathway worsens the arterial calcification, probably by promoting the RANKL expression.

摘要

在这项研究中,我们检测了 Wnt/β-连环蛋白通路通过调节护骨素(OPG)/核因子-κB 受体激活剂配体(RANKL)系统参与动脉钙化的假说。通过免疫组织化学和 Western blot 法测量了华法林诱导的钙化动脉和由平滑肌细胞(SMCs)分化而来的成骨样细胞中的β-连环蛋白表达。通过氯化锂(LiCl)或 Dickkopf 1(DKK1)在体外和体内激活或抑制 Wnt/β-连环蛋白通路。然后通过 von Kossa 染色、Ca 含量测定和碱性磷酸酶(ALP)活性测定来确定钙化水平。通过 Western blot 或实时 PCR 检测骨钙素、OPG 和 RANKL 的表达水平。结果表明,在钙化动脉和 OBL 细胞中,Wnt/β-连环蛋白通路的激活显著增强了钙化,表现为 von Kossa 染色、Ca 含量、ALP 活性和骨钙素表达水平增加(P<0.05),并促进了 RANKL 表达(P<0.05),但对 OPG 表达影响较小。这些结果表明,Wnt/β-连环蛋白通路的激活使动脉钙化恶化,可能是通过促进 RANKL 表达。

相似文献

1
Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.Wnt/β-连环蛋白通路在动脉中层钙化中的作用及其对 OPG/RANKL 系统的影响。
Curr Med Sci. 2019 Feb;39(1):28-36. doi: 10.1007/s11596-019-1996-4. Epub 2019 Mar 13.
2
Implication of receptor activator of NF-κB ligand in Wnt/β-catenin pathway promoting osteoblast-like cell differentiation.核因子κB受体激活剂配体在Wnt/β-连环蛋白通路促进成骨样细胞分化中的作用
J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):818-822. doi: 10.1007/s11596-012-1040-4. Epub 2012 Dec 28.
3
The function and meaning of receptor activator of NF-κB ligand in arterial calcification.核因子κB受体激活剂配体在动脉钙化中的作用及意义
J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):666-671. doi: 10.1007/s11596-015-1487-1. Epub 2015 Oct 22.
4
Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.骨保护素缺乏的平滑肌细胞中钙化增加:对核因子κB受体激活剂配体和白细胞介素6的依赖性。
J Vasc Res. 2014;51(2):118-31. doi: 10.1159/000358920. Epub 2014 Mar 7.
5
GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt/β-catenin signaling pathway.GALNT3 通过增强活性 FGF23 和抑制 wnt/β-连环蛋白信号通路来防止血管平滑肌细胞中磷酸盐诱导的钙化。
Cell Signal. 2022 Dec;100:110477. doi: 10.1016/j.cellsig.2022.110477. Epub 2022 Sep 23.
6
Specific knockdown of WNT8b expression protects against phosphate-induced calcification in vascular smooth muscle cells by inhibiting the Wnt-β-catenin signaling pathway.特异性敲低 WNT8b 表达通过抑制 Wnt-β-连环蛋白信号通路保护血管平滑肌细胞免受磷酸盐诱导的钙化。
J Cell Physiol. 2019 Apr;234(4):3469-3477. doi: 10.1002/jcp.26827. Epub 2018 Nov 21.
7
The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.核因子κB配体受体富含亮氨酸重复序列的G蛋白偶联受体4的受体激活剂促成甲状旁腺激素诱导的血管钙化。
Nephrol Dial Transplant. 2021 Mar 29;36(4):618-631. doi: 10.1093/ndt/gfaa290.
8
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.TRAIL 缺陷通过调节 RANKL 加速动脉粥样硬化中的血管钙化。
PLoS One. 2013 Sep 5;8(9):e74211. doi: 10.1371/journal.pone.0074211. eCollection 2013.
9
RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.核因子κB受体活化因子配体(RANKL)通过RANK-骨形态发生蛋白4(BMP4)依赖的途径增加血管平滑肌细胞钙化。
Circ Res. 2009 May 8;104(9):1041-8. doi: 10.1161/CIRCRESAHA.108.189001. Epub 2009 Mar 26.
10
Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.内脂素-1 通过抑制 RANKL 表达来减轻骨保护素缺陷型小鼠的动脉钙化和骨丢失。
Cardiovasc Res. 2011 Nov 1;92(2):296-306. doi: 10.1093/cvr/cvr200. Epub 2011 Jul 12.

引用本文的文献

1
The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches.骨质疏松症与心血管疾病之间的联系:共享机制、危险因素及治疗方法综述
Osteoporos Int. 2025 Jun 2. doi: 10.1007/s00198-025-07553-7.
2
Warfarin-Induced Calcification: Potential Prevention and Treatment Strategies.华法林诱导的钙化:潜在的预防和治疗策略。
Rev Cardiovasc Med. 2022 Sep 16;23(9):322. doi: 10.31083/j.rcm2309322. eCollection 2022 Sep.
3
Abnormal dental follicle cells: A crucial determinant in tooth eruption disorders (Review).

本文引用的文献

1
Pathogenesis and Management of Vascular Calcification in Patients with End-Stage Renal Disease.终末期肾病患者血管钙化的发病机制与管理
Contrib Nephrol. 2018;196:71-77. doi: 10.1159/000485702. Epub 2018 Jul 24.
2
Mechanism of genistein regulating the differentiation of vascular smooth muscle cells into osteoblasts via the OPG/RANKL pathway.金雀异黄素通过OPG/RANKL途径调控血管平滑肌细胞向成骨细胞分化的机制。
Oncotarget. 2017 Aug 10;8(44):76857-76864. doi: 10.18632/oncotarget.20167. eCollection 2017 Sep 29.
3
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.
异常的牙滤泡细胞:牙齿萌出障碍的关键决定因素(综述)。
Mol Med Rep. 2024 Sep;30(3). doi: 10.3892/mmr.2024.13292. Epub 2024 Jul 19.
4
Mechanisms of Cardiovascular Calcification and Experimental Models: Impact of Vitamin K Antagonists.心血管钙化的机制及实验模型:维生素K拮抗剂的影响
J Clin Med. 2024 Feb 29;13(5):1405. doi: 10.3390/jcm13051405.
5
Advances in the study of miRNAs in chronic kidney disease with cardiovascular complications.伴有心血管并发症的慢性肾脏病中微小RNA的研究进展
Front Physiol. 2023 Nov 23;14:1283597. doi: 10.3389/fphys.2023.1283597. eCollection 2023.
6
The role of miR-433-3p in vascular calcification in type 2 diabetic patients: targeting WNT/β-Catenin and RANKL/RANK/OPG signaling pathways.miR-433-3p 在 2 型糖尿病患者血管钙化中的作用:靶向 WNT/β-连环蛋白和 RANKL/RANK/OPG 信号通路。
Mol Biol Rep. 2023 Nov;50(11):9073-9083. doi: 10.1007/s11033-023-08792-9. Epub 2023 Sep 20.
7
Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.血清和尿液可溶性α-klotho 作为肾脏和血管损伤的标志物。
Nutrients. 2023 Mar 18;15(6):1470. doi: 10.3390/nu15061470.
8
Identification of Key Genes and Pathways Associated with in Bone-Related Disease Based on Bioinformatics.基于生物信息学的骨相关疾病中关键基因和通路的鉴定。
Int J Mol Sci. 2022 May 8;23(9):5250. doi: 10.3390/ijms23095250.
9
Serum Chloride Level Is Associated With Abdominal Aortic Calcification.血清氯离子水平与腹主动脉钙化有关。
Front Cardiovasc Med. 2022 Jan 18;8:800458. doi: 10.3389/fcvm.2021.800458. eCollection 2021.
10
Sclerostin Protects Against Vascular Calcification Development in Mice.硬化蛋白可预防小鼠血管钙化的发生。
J Bone Miner Res. 2022 Apr;37(4):687-699. doi: 10.1002/jbmr.4503. Epub 2022 Feb 15.
Wnt/β-连环蛋白信号通路、疾病与新兴治疗模式。
Cell. 2017 Jun 1;169(6):985-999. doi: 10.1016/j.cell.2017.05.016.
4
A novel role of cellular interactions in vascular calcification.细胞间相互作用在血管钙化中的新作用。
J Transl Med. 2017 May 3;15(1):95. doi: 10.1186/s12967-017-1190-z.
5
Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.2型糖尿病与心血管疾病中的血管钙化:骨保护素、核因子κB受体活化因子配体及肿瘤坏死因子相关凋亡诱导配体的综合作用
Vascul Pharmacol. 2016 Jul;82:30-40. doi: 10.1016/j.vph.2016.02.003. Epub 2016 Feb 24.
6
Vascular calcification: Mechanisms of vascular smooth muscle cell calcification.血管钙化:血管平滑肌细胞钙化的机制
Trends Cardiovasc Med. 2015 May;25(4):267-74. doi: 10.1016/j.tcm.2014.10.021. Epub 2014 Oct 30.
7
Inflammatory, metabolic, and genetic mechanisms of vascular calcification.血管钙化的炎症、代谢和遗传机制。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):715-23. doi: 10.1161/ATVBAHA.113.302070.
8
Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.内脂素-1 通过抑制 RANKL 表达来减轻骨保护素缺陷型小鼠的动脉钙化和骨丢失。
Cardiovasc Res. 2011 Nov 1;92(2):296-306. doi: 10.1093/cvr/cvr200. Epub 2011 Jul 12.
9
[Vascular calcification: types and mechanisms].[血管钙化:类型与机制]
Nefrologia. 2011;31(2):142-7. doi: 10.3265/Nefrologia.pre2010.Nov.10754.
10
Cell biological and physicochemical aspects of arterial calcification.动脉钙化的细胞生物学和物理化学方面。
Kidney Int. 2011 Jun;79(11):1166-77. doi: 10.1038/ki.2011.59. Epub 2011 Mar 16.